Minimizing Medications: The Case for Neuromodulation in Migraine Treatment

Migraine is a relentless and debilitating disease affecting millions worldwide. They are not just head pains – they are usually accompanied by other severe symptoms, ranging from nausea to light sensitivity to aura, which severely affects one’s day-to-day activities.

Prescription or over-the-counter (OTC) drugs have historically been the primary option to treat many neurological conditions, including Migraine. However, it’s crucial to understand that while many of these medications may offer temporary relief, they are not without their systemic side effects.

For migraine patients seeking alternative drug-free treatments, neuromodulation stands out as a promising holistic approach. Let’s explore why one might consider minimizing or even eliminating certain medications in favor of therapies like neuromodulation.

The Downside of Medications

• Ergotamines (Ergomar, Cafergot): While effective for some, they can cause vasoconstriction (narrowing of the blood vessels). This is particularly concerning for heart patients. Additionally, prolonged use may lead to more frequent or severe headaches and cause symptoms like nausea and vomiting.
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Popular pain relievers such as ibuprofen and naproxen can, over time, cause stomach ulcers, bleeding, and other gastrointestinal issues. They might also affect kidney function and heighten the risk of heart ailments.
• Opioids and Barbiturates: The risk of addiction and dependence on drugs like codeine is significant, possibly leading to drowsiness, confusion, and, in severe cases, even respiratory issues.
• Beta-Blockers: Used for both heart conditions and migraines, they may cause fatigue, reduced circulation to extremities, and even exacerbate depressive symptoms.
• Antidepressants: While they can be effective in treating migraines, potential side effects include weight fluctuations, sleep disturbances, and sexual dysfunction.
• Anticonvulsants: Drugs like topiramate can lead to confusion, dizziness, and even birth defects if taken during pregnancy.
• CGRP Inhibitors: This newer class of drugs, while promising, can cause constipation, increased blood pressure, and reactions at the injection site.

While it’s clear and proven that medications can provide relief, they might also introduce new health challenges. Moreover, repeated use of these medications can lead to body building resistance, rendering them less effective over time. There’s also the financial cost of regularly purchasing these medications and the environmental impact of pharmaceutical waste.

An Emerging Solution: Neuromodulation Devices

In short, neuromodulation refers to the process of regulating nerve activity through electrical or chemical methods. Neuromodulation devices designed for Migraine often target the occipital and trigeminal nerve branches, key players in the Migraine storm. By delivering precise, targeted electrical impulses, these devices can inhibit pain signals, reducing or even eliminating the migraine experience. In the context of migraines, devices like Relivion®MG offer an exciting glimpse into the future of non-drug therapies.

Think of neuromodulation as a skilled conductor guiding an orchestra. Similar to how a conductor will use their baton to direct and ensure harmony among musicians, neuromodulation guides our neuropathways, ensuring harmonious function and effectively keeping everything “in sync.”

Some advantages include:

• Non-Invasive: Many neuromodulation therapies are entirely external, meaning no surgical interventions or injections.
• Few to No Side Effects: Unlike medications, there’s no chemical intake, drastically reducing the risk of side effects.
• Reusable: Devices like Relivion MG can be used multiple times, ensuring relief whenever a migraine strikes.
• Evidence-backed: Recent studies show that neuromodulation devices provide significant relief, with some patients achieving complete pain freedom.

In Conclusion

For years, medications have been used as the primary defense against migraines. But with the emergence of neuromodulation, a new door has opened to treatments that offer relief, free from systemic side effects.

If you live with Migraine disease, it might be time to chat with your healthcare provider about neuromodulation options like Relivion MG. As medical science continues to advance, often the most effective solutions are those that align seamlessly with our body’s natural rhythms.

References:

1. Lipton, R. B., Bigal, M. E., Diamond, M., Freitag, F., Reed, M. L., & Stewart, W. F. (2007). Migraine prevalence, disease burden, and the need for preventive therapy. Neurology, 68(5), 343-349.
2. Goadsby, P. J., Lipton, R. B., & Ferrari, M. D. (2002). Migraine—current understanding and treatment. The New England journal of medicine, 346(4), 257-270.
3. Silberstein, S. D. (2000). Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 55(6), 754-762.
4. Tepper, S. J. (2012). Medication-overuse headache. Continuum (Minneapolis, Minn.), 18(4), 807.
5. Diener, H. C., Dodick, D., Evers, S., Holle, D., Jensen, R. H., Lipton, R. B., … & Silberstein, S. (2019). Pathophysiology, prevention, and treatment of medication overuse headache. The Lancet Neurology, 18(9), 891-902.
6. Chou, D. E., & Gross, G. J. (2020). Medication overuse headache: biobehavioral correlates and mechanisms of transformation. Headache: The Journal of Head and Face Pain, 60(1), 200-211.
7. Starling, A. J. (2018). Diagnosis and management of headache. Mayo Clinic Proceedings, 93(12), 1842-1850.
8. Chiang, C. C., Schwedt, T. J., Wang, S. J., & Dodick, D. W. (2016). Treatment of medication-overuse headache: A systematic review. Cephalalgia, 36(4), 371-386.
9. Ashina, S., Buse, D. C., Maizels, M., Manack, A. N., Serrano, D., & Turkel, C. (2020). Self‐reported triptan side effects: Results from the American Migraine Prevalence and Prevention (AMPP) study. Headache: The Journal of Head and Face Pain, 60(7), 1414-1431.
10. Brin, M. F., & Dodick, D. W. (2004). Neuromodulation for headache treatment: the end of the pharmacological era?. Current treatment options in neurology, 6(1), 71-81.
11. Martelletti, P., & Jensen, R. H. (2019). Neuromodulation in migraine: state of the art and perspectives. Expert review of neurotherapeutics, 19(9), 871-879.